Related Experiment Videos
[Cold agglutinins with new specificity against type 2 chains]
1Institut für Immunologie, Blutbank, Universität Heidelberg, Deutschland.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine
|January 1, 1994
Summary
Two novel IgM lambda cold agglutinins (CA) recognize both linear and branched type 2 chains on newborn and adult red cells, including animal cells. This specificity broadens understanding of cold agglutinin interactions.
Area of Science:
- Immunology
- Hematology
- Glycobiology
Background:
- Cold agglutinins (CAs) are autoantibodies, typically IgM, that bind red blood cells at low temperatures.
- CA specificity is often directed against red blood cell surface antigens, particularly the I/i blood group system.
- Understanding CA specificity is crucial for diagnosing and managing cold agglutinin disease.
Observation:
- Two specific IgM lambda cold agglutinins, designated ZI and BR, were isolated and characterized.
- These CAs demonstrated reactivity with both adult and newborn human red blood cells.
- Reactivity extended to I- and i-active animal red blood cells, indicating a broad antigen recognition profile.
Findings:
- The ZI and BR cold agglutinins were inhibited by both linear and branched type 2 carbohydrate chains.
- Enzymatic treatment with endo-beta-galactosidase, which cleaves type 2 chains, abolished the reactivity of both CAs.
- These findings confirm that both CAs specifically recognize and bind to type 2 carbohydrate chains, irrespective of their linearity or branching.
Implications:
- The characterization of these CAs expands the known specificities within the IgM cold agglutinin group.
- This discovery may refine diagnostic approaches for certain autoimmune hemolytic anemias.
- Further research into type 2 chain recognition by antibodies could offer new therapeutic targets.